Phytotherapy, drug regulation

Authors:Prof. Dr. med. Peter Altmeyer, Prof. Dr. med. Martina Bacharach-Buhles

All authors of this article

Last updated on: 08.01.2025

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

The monographs of the German Commission E have worldwide significance. In accordance with §25 AMG 76, Commission E consists of 24 experts who must demonstrate special knowledge - scientific and/or practical - of the phytotherapeutic therapeutic direction and substance group.
The results of the factual discussions, in which the professional societies or individual scientists were also able to participate, were set out in positive and negative monographs published in the Federal Gazette. Internationally active expert groups that deal with phytotherapeutic therapy directions and substance groups are:

The monographs contain detailed information on the drugs used and their ingredients and present the results of the available pharmacological, pharmacokinetic, toxicological and clinical studies.

see also Phytotherapy traditional and Rational phytotherapy

LiteratureThis section has been translated automatically.

  1. Krenn L (2013)ESCOP on-line: new monographs available! Phytomedicines 20:469.

Authors

Last updated on: 08.01.2025